🚀 VC round data is live in beta, check it out!

Corbion Valuation Multiples

Discover revenue and EBITDA valuation multiples for Corbion and similar public comparables like Anhui Huaheng, CVR Partners, Takara Bio, SunOpta and more.

Corbion Overview

About Corbion

Corbion NV is a Netherlands-based company that produces food ingredients and biobased chemicals. The company distinguishes between the segments Functional Ingredients & Solutions and Health & Nutrition. The Company is a leader in sustainable bio-based ingredients and lactic acid derivatives. The company provides solutions for food preservation, health, and bioplastics through fermentation technology. Its products serve industries including food, pharmaceuticals, personal care, and packaging. Corbion focuses on innovation and sustainability to preserve food, health, and the planet. Geographically, it derives a majority of its revenue from the U.S.


Founded

1903

HQ

Netherlands

Employees

2.4K

Financials (LTM)

Revenue: $1B
EBITDA: $244M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Corbion Financials

Corbion reported last 12-month revenue of $1B and EBITDA of $244M.

In the same LTM period, Corbion generated $419M in gross profit, $244M in EBITDA, and $94M in net income.

Revenue (LTM)


Corbion P&L

In the most recent fiscal year, Corbion reported revenue of $1B and EBITDA of $241M.

Corbion expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Corbion forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$1BXXX$1BXXXXXXXXX
Gross Profit$419MXXX$382MXXXXXXXXX
Gross Margin28%XXX26%XXXXXXXXX
EBITDA$244MXXX$241MXXXXXXXXX
EBITDA Margin16%XXX16%XXXXXXXXX
EBIT Margin10%XXX9%XXXXXXXXX
Net Profit$94MXXX$88MXXXXXXXXX
Net Margin6%XXX6%XXXXXXXXX
Net Debt——$410MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Corbion Stock Performance

Corbion has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Corbion's stock price is $22.09.

See Corbion trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B-0.3%XXXXXXXXX$1.53

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Corbion Valuation Multiples

Corbion trades at 1.2x EV/Revenue multiple, and 7.4x EV/EBITDA.

See valuation multiples for Corbion and 15K+ public comps

EV / Revenue (LTM)


Corbion Financial Valuation Multiples

As of March 24, 2026, Corbion has market cap of $1B and EV of $2B.

Equity research analysts estimate Corbion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Corbion has a P/E ratio of 13.6x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue1.2xXXX1.2xXXXXXXXXX
EV/EBITDA7.4xXXX7.4xXXXXXXXXX
EV/EBIT12.6xXXX12.8xXXXXXXXXX
EV/Gross Profit4.3xXXX4.7xXXXXXXXXX
P/E13.6xXXX14.4xXXXXXXXXX
EV/FCF17.1xXXX16.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Corbion Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Corbion Margins & Growth Rates

Corbion's revenue in the last 12 month grew by 1%.

Corbion's revenue per employee in the last FY averaged $0.6M.

Corbion's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Corbion's rule of X is 19% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Corbion and other 15K+ public comps

Corbion Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth1%XXX0%XXXXXXXXX
EBITDA Margin16%XXX16%XXXXXXXXX
EBITDA Growth5%XXX4%XXXXXXXXX
Rule of 40—XXX17%XXXXXXXXX
Bessemer Rule of X—XXX19%XXXXXXXXX
Revenue per Employee—XXX$0.6MXXXXXXXXX
S&M Expenses to Revenue6%XXX6%XXXXXXXXX
G&A Expenses to Revenue9%XXX8%XXXXXXXXX
R&D Expenses to Revenue3%XXX3%XXXXXXXXX
Opex to Revenue—XXX17%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Corbion Public Comps

See public comps and valuation multiples for other Bioindustrials comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Anhui HuahengXXXXXXXXXXXXXXXXXX
CVR PartnersXXXXXXXXXXXXXXXXXX
Takara BioXXXXXXXXXXXXXXXXXX
SunOptaXXXXXXXXXXXXXXXXXX
FMCXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Corbion M&A Activity

Corbion acquired XXX companies to date.

Last acquisition by Corbion was on XXXXXXXX, XXXXX. Corbion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Corbion

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Corbion Investment Activity

Corbion invested in XXX companies to date.

Corbion made its latest investment on XXXXXXXX, XXXXX. Corbion invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Corbion

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Corbion

When was Corbion founded?Corbion was founded in 1903.
Where is Corbion headquartered?Corbion is headquartered in Netherlands.
How many employees does Corbion have?As of today, Corbion has over 2K employees.
Is Corbion publicly listed?Yes, Corbion is a public company listed on Euronext Amsterdam.
What is the stock symbol of Corbion?Corbion trades under CRBN ticker.
When did Corbion go public?Corbion went public in 1984.
Who are competitors of Corbion?Corbion main competitors are Anhui Huaheng, CVR Partners, Takara Bio, SunOpta.
What is the current market cap of Corbion?Corbion's current market cap is $1B.
What is the current revenue of Corbion?Corbion's last 12 months revenue is $1B.
What is the current revenue growth of Corbion?Corbion revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Corbion?Current revenue multiple of Corbion is 1.2x.
Is Corbion profitable?Yes, Corbion is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Corbion?Corbion's last 12 months EBITDA is $244M.
What is Corbion's EBITDA margin?Corbion's last 12 months EBITDA margin is 16%.
What is the current EV/EBITDA multiple of Corbion?Current EBITDA multiple of Corbion is 7.4x.
What is the current FCF of Corbion?Corbion's last 12 months FCF is $105M.
What is Corbion's FCF margin?Corbion's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Corbion?Current FCF multiple of Corbion is 17.1x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial